Skip to main content
Clinical Trials/IRCT20220411054499N1
IRCT20220411054499N1
Recruiting
Phase 3

Comparison of the effect of intraperitoneal ropivacaine and ketamine on pain control after cholecystectomy

Arak University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Cholecystitis.
Sponsor
Arak University of Medical Sciences
Enrollment
120
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age 18\-60 years old
  • Patients indicated for laparoscopic cholecystectomy
  • All patients with a VAS score equal or greater than 5

Exclusion Criteria

  • Hypersensitivity to Ketamine or Ropivacaine
  • Has cardiovascular, lung or mental illness
  • Arbitrary use of any additional painkillers after surgery
  • Patients indicated for open cholecystectomy

Outcomes

Primary Outcomes

Not specified

Similar Trials